Stay updated on Atezolizumab in Esophageal Cancer: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.

Latest updates to the Atezolizumab in Esophageal Cancer: Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov record for the atezolizumab and tiragolumab study is now available, presenting its trial design, participant criteria, treatment groups, outcomes, and locations. The record indicates the study is completed and no longer recruiting.SummaryDifference100%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 error.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check36 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now shows a 403 Forbidden error with a basic header and a Home link. This replaces the previous display of the trial's details, locations, and study information.SummaryDifference17%

- Check57 days agoChange DetectedThe locations count is updated to 166 with Siriraj Hospital (Bangkok, Thailand) removed from the list of sites. The study status has changed from Active, not recruiting to Completed.SummaryDifference0.3%

Stay in the know with updates to Atezolizumab in Esophageal Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.